Synthetic Data as a Catalyst for Regulatory Compliance: GDPR, HIPAA, and the AI Act
Published by Entrobit · April 2026
The Data Is There. The Law Says No.
A pharmaceutical company in Germany wants to build a predictive model for adverse drug reactions with a research hospital in the United States. The dataset they need to share contains patient demographics, genetic markers, medication histories, clinical outcomes. Exactly the kind of data that makes models work. Exactly the kind of data that privacy regulations were written to protect.
European law restricts international transfers of personal data. American healthcare rules constrain identifiable health information. The EU AI Act adds governance requirements for training data in high-risk AI systems. Each framework has different definitions, different rules, different enforcement.
The result: the data exists, the science is clear, both partners are willing, and the collaboration never happens because the legal complexity makes sharing raw data impractical.
Synthetic data can break this deadlock. But only if it's generated and governed in a way that actually satisfies the regulations in play. "It's synthetic, so it's fine" is not a legal argument. Understanding what each regulation actually requires is the prerequisite.
GDPR: Is Synthetic Data Personal Data?
GDPR applies to "personal data," defined as information relating to an identified or identifiable natural person. The central question: does a synthetic dataset count?
Recital 26 provides the framework. Data rendered anonymous, such that the data subject is no longer identifiable, falls outside the regulation's scope. The standard isn't absolute anonymity but reasonable identifiability: all means "reasonably likely to be used" for identification should be considered, accounting for cost, time, technology, and foreseeable developments.
The Case for Exemption
If synthetic data is generated through a process that introduces sufficient abstraction, such that no individual can be re-identified from synthetic records using reasonable means, it can be argued the data is no longer personal data and GDPR doesn't apply.
Differentially private synthetic data strengthens this argument considerably. The formal (ε, δ) guarantee mathematically bounds how much information the synthetic output can reveal about any training individual. That's precisely the kind of technical safeguard Recital 26 contemplates.
The Case for Caution
European data protection authorities haven't granted blanket exemptions. The European Data Protection Board has noted that re-identification risk depends on the specific technique, the data's nature, and available auxiliary information. A synthetic dataset from a generator that memorizes training examples could retain identifiable information despite being "synthetic."
Bottom line: GDPR compliance isn't an inherent property of synthetic data. It depends on how the data was generated, what privacy mechanisms were applied, and whether re-identification risk was assessed. Organizations claiming exemption should be ready to document the entire process.
Don't Forget the DPIA
Even if the synthetic output isn't personal data, generating it from personal data is a processing activity. For high-risk processing, Article 35 requires a Data Protection Impact Assessment. The DPIA should document the purpose, the privacy mechanism, the re-identification risk evaluation, and governance controls around the original data.
HIPAA: Two Paths to De-identification
HIPAA protects "protected health information" (PHI) held by covered entities and business associates. It offers two de-identification pathways under 45 CFR §164.514.
Safe Harbor
Remove 18 specific identifier categories (names, sub-state geography, dates beyond year, phone numbers, SSNs, etc.) and certify there's no actual knowledge that remaining data could identify anyone.
Synthetic data can satisfy Safe Harbor if the generation process doesn't reproduce the 18 identifiers and synthetic records can't be traced to individuals. Since synthetic records come from learned statistical patterns rather than being copied, they typically don't contain the identifiers Safe Harbor targets. But "typically" isn't "always." Verify, don't assume.
Expert Determination
A qualified statistical expert certifies that re-identification risk is "very small." This is more flexible than Safe Harbor: instead of mechanically removing identifiers, it requires a statistical analysis.
DP synthetic data is particularly well-suited here. The formal privacy guarantee directly bounds information leakage, giving the expert a quantitative foundation. Combined with empirical testing (nearest-neighbor distances, membership inference success rates), it provides a comprehensive evidence base.
The Business Associate Question
If a third-party platform generates synthetic data from PHI, the platform operator may qualify as a business associate under HIPAA and need a Business Associate Agreement. Clarify this before engaging with any provider.
The EU AI Act: Data Governance for Training Data
The AI Act, entering into force in stages since 2024, imposes data governance requirements on high-risk AI systems (healthcare, employment, credit scoring, law enforcement, and others in Annex III).
Article 10
Training, validation, and testing datasets for high-risk systems must follow appropriate governance practices addressing quality, bias, data gaps, and relevant statistical properties.
Synthetic data intersects with Article 10 in both directions. It can help satisfy the requirements by augmenting underrepresented populations, generating edge cases, and rebalancing class distributions. But synthetic data used for training must itself meet those requirements. You can't just generate synthetic data and assume it's compliant. Quality evaluations (distributional fidelity, TSTR utility, fairness metrics) become part of your compliance documentation.
Article 53
The AI Act explicitly mentions synthetic data as a tool for safe development and testing in regulatory sandboxes. This institutional endorsement creates a favorable context for adoption in the EU.
The Documentation Burden
Article 11 requires extensive documentation of training data, methodologies, and evaluations for high-risk systems. Synthetic data with documented privacy guarantees (ε value, mechanism, evaluation metrics) slots directly into this: the privacy and quality parameters become part of the AI system's compliance record.
How the Approaches Compare
| Approach | Mechanism | GDPR Status | HIPAA Status | Re-identification Risk |
|---|---|---|---|---|
| Anonymization | Remove/modify identifiers | Outside GDPR if truly anonymous | Safe Harbor pathway | Demonstrated vulnerabilities to linkage attacks (Sweeney, 1997: 87% of U.S. population uniquely identified by zip, birth date, sex) |
| Pseudonymization | Replace identifiers with tokens | Still personal data under GDPR | Doesn't qualify as de-identification | Reversible with key |
| Synthetic (no DP) | Generate from learned distributions | Arguable; depends on implementation | Case-by-case Expert Determination | No formal guarantee; may memorize |
| DP Synthetic | Generate with formal guarantee | Strongest anonymization argument | Strong basis for Expert Determination | Provably bounded by ε |
Walking Through the Scenario
Back to the German hospital and American research team. Here's how synthetic data navigates the regulatory maze.
Step 1. The hospital identifies the dataset as GDPR-regulated personal data with HIPAA-equivalent sensitivity. A DPIA documents the purpose (adverse drug reaction research), the privacy mechanism (DP synthesis at ε = 1), and risk mitigation.
Step 2. Synthetic data is generated on-premises using a DP synthesizer with ε = 1, selected for the data's sensitivity and intended use. The original data never leaves the hospital's governance perimeter.
Step 3. The synthetic output is evaluated: distributional fidelity (marginal and pairwise distributions), utility (TSTR on a preliminary adverse drug reaction model), and privacy (nearest-neighbor distances, membership inference attack results). The formal ε = 1 guarantee is documented.
Step 4. Evaluation results, ε guarantee, methodology, and DPIA are compiled into a compliance package. Legal counsel reviews against GDPR Recital 26, HIPAA Expert Determination, and AI Act Article 10.
Step 5. The synthetic dataset, documented as anonymized data with a formal privacy guarantee, is shared with the U.S. partner. Because it's no longer personal data under GDPR (supported by the ε guarantee and re-identification analysis), Chapter V transfer restrictions don't apply.
Organizations that have deployed synthetic data pipelines for tabular and time-series data have navigated exactly this kind of multi-jurisdictional challenge. The key enabler is a platform integrating generation, privacy mechanisms, evaluation, and documentation in a single governed workflow, where compliance is built into the output rather than bolted on afterward.
The Direction of Travel
The regulatory landscape is moving toward a world where formal privacy guarantees will be expected, not exceptional. GDPR enforcement against insufficient anonymization is getting sharper. HIPAA scrutiny of de-identification methods is increasing. The academic literature on re-identification attacks against naive techniques grows every year.
Organizations investing now in synthetic data capabilities with proper privacy mechanisms, rigorous evaluation, and thorough documentation will be better positioned for what's coming. Those still relying on traditional anonymization, with its demonstrated vulnerability to re-identification, carry increasing regulatory and reputational risk.
Synthetic data isn't a compliance silver bullet. It's a tool that must be deployed with the same rigor, documentation, and governance as any compliance-critical process. The organizations that succeed will treat synthetic data generation as a governed enterprise capability, not a data science experiment.
References: EU GDPR Recital 26; HIPAA 45 CFR §164.514; EU AI Act Articles 10, 11, 53; El Emam et al. (2020), Evaluating Identity Disclosure Risk in Fully Synthetic Health Data; Sweeney (1997), Weaving Technology and Policy Together to Maintain Confidentiality; OpenDP / SmartNoise documentation.